SavedAdd your journal

Journals / Türk Kardiyoloji Derneği Arşivi / 2012 / Cilt: 40 - Sayı: 5

Elektrokardiyografik sağ ventrikül hipertrofisi mitral darlığı olan hastalarda pulmoner hipertansiyonun ciddiyetini belirler

Electrocardiographic right ventricular hypertrophy predicts the severity of pulmonary hypertension in patients with mitral stenosis)

Ali DENİZ
Esmeray ACARTÜRK
Mücahit TÜFENK
Pages
405–408
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Electrocardiographic RVH was diagnosed when at least 2 of the following criteria were present at the same time: V1R+V5S or V6S >10.5 mm, V1R >6 mm, R >S in V1, V1 S

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Rheumatic heart disease is still common in developing countries.
📊
Key Findings & Data:Mitral stenosis impedes left atrial emptying, increases left atrial and pulmonary venous pressure, and thus causes pulmonary hypertension.
💡
Conclusion & Impact:Electrocardiographic RVH was diagnosed when at least 2 of the following criteria were present at the same time: V1R+V5S or V6S >10.5 mm, V1R >6 mm, R >S in V1, V1 S
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Rheumatic heart disease is still common in developing countries. Mitral stenosis impedes left atrial emptying, increases left atrial and pulmonary venous pressure, and thus causes pulmonary hypertension. Pulmonary hypertension results in right ventricular hypertrophy (RVH), implying that the disease is long lasting and needs interventional treatment. The aim of our study was to predict the severity of pulmonary hypertension in patients with mitral stenosis by evaluating electrocardiographic RVH. Study design: Patients admitted to our hospital with mitral stenosis were evaluated. Their clinical, electrocardiographic, and echocardiographic parameters were recorded. Electrocardiographic RVH was diagnosed when at least 2 of the following criteria were present at the same time: V1R+V5S or V6S >10.5 mm, V1R >6 mm, R >S in V1, V1 S

Özet

Amaç: Romatizmal kalp hastalığı gelişmekte olan ülkelerde hala yaygındır. Mitral darlığı sol atriyum doluşunu engelleyerek sol atriyum ve pulmoner venöz basıncı artırır ve pulmoner hipertansiyona yol açar. Pulmoner hipertansiyon ise hastalığın uzun süredir var olduğunu ve girişimsel veya cerrahi tedavi gerektiğini gösteren sağ ventrikül hipertrofisine (SVH) yol açar. Bu çalışmada, elektrokardiyografik (EKG) SVH değerlendirilerek mitral darlığın yol açtığı pulmoner hipertansiyonun ciddiyeti araştırıldı.Çalışma planı: Hastanemize başvuran ve mitral darlığı tanısı alan hastalar çalışmaya alındı. Klinik, EKG ve ekokardiyografik veriler kaydedildi. Elektrokardiyografik olarak SVH tanısı şu bulgulardan en az ikisinin varlığı ile koyuldu: V1R+V5S veya V6S >10.5 mm, V1R >6 mm, V1’de R >S, V1 S

🔖

Cite This Article

DENİZ, A., ACARTÜRK, E., TÜFENK, M. (2022). Elektrokardiyografik sağ ventrikül hipertrofisi mitral darlığı olan hastalarda pulmoner hipertansiyonun ciddiyetini belirler. Türk Kardiyoloji Derneği Arşivi, Cilt: 40 - Sayı: 5, 405–408. https://ajindex.com/articles/633043

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. REFERENCES1. Padmavati S. Rheumatic fever and rheumatic heart disease in India at the turn of the century. Indian Heart J 2001
  2. Ozer O, Davutoglu V, Sari I, Akkoyun DC, Sucu M. The spectrum of rheumatic heart disease in the southeastern Anatolia endemic region: results from 1900 patients. J Heart Valve Dis 2009
  3. Hancock EW, Deal BJ, Mirvis DM, Okin P, Kligfield P, Gettes LS, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology
  4. the American College of Cardiology Foundation
  5. and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol 2009
  6. Quiñones MA, Otto CM, Stoddard M, Waggoner A, Zoghbi WA
  7. Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Recommendations for quantification of Doppler echocardiography: a report from the Doppler Quantification Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. J Am Soc Echocardiogr 2002
  8. Otto CM, Bonow RO. Valvular heart disease. In: Bonow RO, Mann DL, Zipes DP, Libby P, editors. Braunwald’s heart disease: a textbook of cardiovascular medicine. 9th ed. Philadelphia: Elsevier Science
  9. p. 1468-530. 6. Fowler NO, Noble WJ, Giarratano SJ, Mannix EP. The clinical estimation of pulmonary hypertension accompanying mitral stenosis. Am Heart J 1955
  10. Semler HJ, Pruitt RD. An electrocardiographic estimation of the pulmonary vascular obstruction in 80 patients with mitral stenosis. Am Heart J 1960
  11. Murphy ML, Thenabadu PN, de Soyza N, Doherty JE, Meade J, Baker BJ, et al. Reevaluation of electrocardiographic criteria for left, right and combined cardiac ventricular hypertrophy. Am J Cardiol 1984
  12. Donoso E, Jick S, Braunwald E, Lamelas M, Grishman A. The spatial vectorcardiogram in mitral valve disease. Am Heart J 1957
  13. Nordet P. WHO/ISFC Global programme for the prevention and control of RF/RHD. J Int Fed Cardiol 1993
  14. Eisenberg MJ. Rheumatic heart disease in the developing world: prevalence, prevention, and control. Eur Heart J 1993
  15. American College of Cardiology